George Cardoza, Chief Financial Officer at SOPHiA GENETICS SA (SOPH), sold 1,548 shares at $4.79 ($7K) on 2026-03-19, disclosed to the SEC on 2026-03-20.
Scheduled sale ($7k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.79 | 774 | $4K | 50.0% |
| 2 | $4.79 | 774 | $4K | 50.0% |
| Total | $4.79 avg | 1,548 | $7K | 100% |
| Filing → |
| SOPH | BUY | 2026-06-05 | $99K | — | Filing → |
| SOPH | SELL | 2026-04-10 | $7K | — | Filing → |
| SOPH | SELL | 2026-04-08 | $24K | — | Filing → |